| Product Code: ETC7648585 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Communicable Diseases Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 Israel Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Israel Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Israel Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in Israel |
4.2.2 Growing government initiatives to improve healthcare infrastructure |
4.2.3 Technological advancements in treatment methods for communicable diseases |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications |
4.3.2 Limited access to healthcare services in remote areas of Israel |
4.3.3 Lack of awareness about prevention and early detection of communicable diseases |
5 Israel Communicable Diseases Treatment Market Trends |
6 Israel Communicable Diseases Treatment Market, By Types |
6.1 Israel Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 Israel Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 Israel Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 Israel Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 Israel Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 Israel Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 Israel Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 Israel Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 Israel Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 Israel Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 Israel Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 Israel Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 Israel Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 Israel Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 Israel Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 Israel Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 Israel Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Israel Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Israel Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Israel Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Israel Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 Israel Communicable Diseases Treatment Market Export to Major Countries |
7.2 Israel Communicable Diseases Treatment Market Imports from Major Countries |
8 Israel Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Rate of adoption of new treatment technologies in communicable diseases |
8.2 Number of patients receiving timely and appropriate treatment |
8.3 Percentage of population covered under government healthcare initiatives |
9 Israel Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 Israel Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Israel Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 Israel Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 Israel Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Israel Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Communicable Diseases Treatment Market - Competitive Landscape |
10.1 Israel Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here